Saint-Laurent, Canada

Maxence Bos

USPTO Granted Patents = 4 

Average Co-Inventor Count = 13.0

ph-index = 3

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Maxence Bos: Innovator in Neurodegenerative Disorder Treatments

Introduction

Maxence Bos is a notable inventor based in Saint-Laurent, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating neurodegenerative disorders. With a total of four patents to his name, Bos is recognized for his innovative approaches to medical challenges.

Latest Patents

Among his latest patents, Bos has developed heterocyclic compounds that act as agonists for the Triggering Receptor Expressed on Myeloid Cells 2 (TREM2). These compounds are designed to activate TREM2, which plays a crucial role in the immune response within the brain. The disclosures include pharmaceutical compositions that utilize these compounds, along with methods for their application in treating neurodegenerative disorders. Additionally, the patents provide intermediates that are useful in the synthesis of these innovative compounds.

Career Highlights

Throughout his career, Maxence Bos has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Amgen Inc. and Vigil Neuroscience, Inc. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Lara C Czabaniuk and Timothy Hopper. Their collaborative efforts have further advanced the research and development of innovative treatments in the pharmaceutical industry.

Conclusion

Maxence Bos stands out as an influential inventor in the realm of neurodegenerative disorder treatments. His patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…